WO2007051133A3 - Substituted thiazoles and their use - Google Patents
Substituted thiazoles and their use Download PDFInfo
- Publication number
- WO2007051133A3 WO2007051133A3 PCT/US2006/060248 US2006060248W WO2007051133A3 WO 2007051133 A3 WO2007051133 A3 WO 2007051133A3 US 2006060248 W US2006060248 W US 2006060248W WO 2007051133 A3 WO2007051133 A3 WO 2007051133A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- directed
- compounds
- oab
- channel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
Abstract
The invention is directed to novel substituted thiazole compounds. Specifically, the invention is directed to compounds according to Formula (I): wherein R1 and R2 are as defined below, and to pharmaceutically-acceptable salts thereof. The compounds are large conductance calcium-activated K channel (BKCa channel) openers, which can be used in the treatment of urinary conditions, including OAB. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of treating urinary conditions, such as OAB, using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73029805P | 2005-10-26 | 2005-10-26 | |
US60/730,298 | 2005-10-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007051133A2 WO2007051133A2 (en) | 2007-05-03 |
WO2007051133A3 true WO2007051133A3 (en) | 2007-12-13 |
Family
ID=37968661
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/060248 WO2007051133A2 (en) | 2005-10-26 | 2006-10-26 | Substituted thiazoles and their use |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR056720A1 (en) |
PE (1) | PE20070530A1 (en) |
TW (1) | TW200732314A (en) |
WO (1) | WO2007051133A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2280948A1 (en) | 2008-04-09 | 2011-02-09 | Mitsubishi Tanabe Pharma Corporation | Pyrimidine, pyridine and triazine derivatives as maxi-k channel openers. |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4746741A (en) * | 1986-06-19 | 1988-05-24 | Eastman Kodak Company | N,N'-bis[2-(3-methylphenyl)ethyl]-perylene-3,4:9,10-bis (dicarboximide) compound use thereof in multi-active photoconductive insulating elements exhibiting far red sensitivity |
US5288863A (en) * | 1991-05-03 | 1994-02-22 | Egis Gyogyszergyar Rt. | Process for the preparation of high-purity 1-(3-chloro-phenyl)-4-methyl-7,8-dimethoxy-5H-2,3-benzodiazepine |
US5462959A (en) * | 1991-03-25 | 1995-10-31 | Akzo N.V. | 4-aryl-imidazole derivatives |
US5668286A (en) * | 1994-03-15 | 1997-09-16 | Pharmacia & Upjohn Company | Oxazolidinone derivatives and pharmaceutical compositions containing them |
US20030161860A1 (en) * | 2002-02-07 | 2003-08-28 | Taneja Subhash Chandra | Novel substituted aryl alkenoic acid heterocyclic amides |
US20040127527A1 (en) * | 2001-04-16 | 2004-07-01 | Mitsuya Hongu | Large conductance calcium-activated k channel opener |
US20050054851A1 (en) * | 2001-08-30 | 2005-03-10 | Claudia Betschart | Pyrrolo pyrimidines as agents for the inhibition of cystein proteases |
-
2006
- 2006-10-24 AR ARP060104641A patent/AR056720A1/en not_active Application Discontinuation
- 2006-10-24 TW TW095139076A patent/TW200732314A/en unknown
- 2006-10-24 PE PE2006001294A patent/PE20070530A1/en not_active Application Discontinuation
- 2006-10-26 WO PCT/US2006/060248 patent/WO2007051133A2/en active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4746741A (en) * | 1986-06-19 | 1988-05-24 | Eastman Kodak Company | N,N'-bis[2-(3-methylphenyl)ethyl]-perylene-3,4:9,10-bis (dicarboximide) compound use thereof in multi-active photoconductive insulating elements exhibiting far red sensitivity |
US5462959A (en) * | 1991-03-25 | 1995-10-31 | Akzo N.V. | 4-aryl-imidazole derivatives |
US5288863A (en) * | 1991-05-03 | 1994-02-22 | Egis Gyogyszergyar Rt. | Process for the preparation of high-purity 1-(3-chloro-phenyl)-4-methyl-7,8-dimethoxy-5H-2,3-benzodiazepine |
US5668286A (en) * | 1994-03-15 | 1997-09-16 | Pharmacia & Upjohn Company | Oxazolidinone derivatives and pharmaceutical compositions containing them |
US20040127527A1 (en) * | 2001-04-16 | 2004-07-01 | Mitsuya Hongu | Large conductance calcium-activated k channel opener |
US20050054851A1 (en) * | 2001-08-30 | 2005-03-10 | Claudia Betschart | Pyrrolo pyrimidines as agents for the inhibition of cystein proteases |
US20030161860A1 (en) * | 2002-02-07 | 2003-08-28 | Taneja Subhash Chandra | Novel substituted aryl alkenoic acid heterocyclic amides |
Also Published As
Publication number | Publication date |
---|---|
TW200732314A (en) | 2007-09-01 |
WO2007051133A2 (en) | 2007-05-03 |
PE20070530A1 (en) | 2007-05-31 |
AR056720A1 (en) | 2007-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007136650A3 (en) | Method and compositions for treating hematological malignancies | |
WO2009046842A3 (en) | Thiazol derivatives for treating cancer | |
WO2007092095A3 (en) | [4-(benzo [b] thi0phen-2-yl) pyrimidin-2yl] -amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases. | |
WO2009051244A1 (en) | Heterocyclic compound | |
TW200745004A (en) | Novel compounds, their preparation and use | |
WO2007103550A3 (en) | Substituted aminothiazole derivatives with anti-hcv activity | |
TN2011000053A1 (en) | Organic compounds | |
WO2007019191A3 (en) | Thiazolopyrimidine kinase inhibitors | |
TW200637550A (en) | Thiazole-4-carboxamide derivatives as mGluR5 antagonists | |
WO2009154300A3 (en) | Heterocyclic compound and use thereof | |
WO2007109105A3 (en) | Flavivirus inhibition by sultams and related compounds | |
WO2009026166A3 (en) | Antiinfective flavonol compounds and methods of use thereof | |
WO2007025897A3 (en) | Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives | |
TW200700069A (en) | Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives | |
CL2007001530A1 (en) | Thiazole derived compounds, fbpase inhibitors; Preparation process; pharmaceutical composition; and use for the treatment and / or prophylaxis of diabetes mellitus type i, ii and iii, fasting glucose imbalance, glucose tolerance imbalance and diabetes complications. | |
EA200970098A1 (en) | WATER TREATMENT DOWNHOUSE FOR OIL-BASED DRILLING SOLUTIONS | |
NO20082096L (en) | Azaindole-2-karboksamidderivativer | |
MY157116A (en) | Novel seh inhibitors and their use | |
TN2010000038A1 (en) | Organic compounds | |
SG151306A1 (en) | Novel benzothiazoles and the use thereof as medicaments | |
WO2008000421A3 (en) | Thiazolyl urea derivatives as phosphatidylinositol 3-kinase inhibitors | |
WO2007134149A3 (en) | 3,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as cetp inhibitors | |
PE20060942A1 (en) | NONADEPSIPEPTIDE DERIVATIVES II AS BACTERICIDE AGENTS | |
ATE515494T1 (en) | NEW COMPOUNDS, THEIR PRODUCTION AND USE | |
DE602005024539D1 (en) | NEW COMPOUNDS, ITS MANUFACTURE AND USE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06839551 Country of ref document: EP Kind code of ref document: A2 |